Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02. (Q46820235)
Jump to navigation
Jump to search
scientific article published in October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02. |
scientific article published in October 2008 |
Statements
1 reference
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02. (English)
1 reference
Jarrod P Holmes
1 reference
Jeremy D Gates
1 reference
Linda C Benavides
1 reference
Matthew T Hueman
1 reference
Mark G Carmichael
1 reference
Ritesh Patil
1 reference
Dianna Craig
1 reference
Elizabeth A Mittendorf
1 reference
Alexander Stojadinovic
1 reference
Sathibalan Ponniah
1 reference
George E Peoples
1 reference
1 October 2008
1 reference
1 reference
113
1 reference
7
1 reference
1666-1675
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference